Cargando…

The landscape of metastatic progression patterns across major human cancers

The majority of patients with solid malignancies die from metastatic burden. However, our current understanding of the mechanisms and resulting patterns of dissemination is limited. Here, we analyzed patterns of metastatic progression across 16 major cancer types in a cohort of 1008 patients with me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budczies, Jan, von Winterfeld, Moritz, Klauschen, Frederick, Bockmayr, Michael, Lennerz, Jochen K., Denkert, Carsten, Wolf, Thomas, Warth, Arne, Dietel, Manfred, Anagnostopoulos, Ioannis, Weichert, Wilko, Wittschieber, Daniel, Stenzinger, Albrecht
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381616/ https://www.ncbi.nlm.nih.gov/pubmed/25402435

Ejemplares similares

Classical pathology and mutational load of breast cancer – integration of two worlds
por: Budczies, Jan, et al.
Publicado: (2015)

Who Is at Risk for Diagnostic Discrepancies? Comparison of Pre- and Postmortal Diagnoses in 1800 Patients of 3 Medical Decades in East and West Berlin
por: Wittschieber, Daniel, et al.
Publicado: (2012)

Ioncopy: a novel method for calling copy number alterations in amplicon sequencing data including significance assessment
por: Budczies, Jan, et al.
Publicado: (2016)

New network topology approaches reveal differential correlation patterns in breast cancer
por: Bockmayr, Michael, et al.
Publicado: (2013)

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences
por: Kriegsmann, Mark, et al.
Publicado: (2014)

Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach
por: Wienert, Stephan, et al.
Publicado: (2012)

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
por: Stenzinger, Albrecht, et al.
Publicado: (2013)

Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm
por: Stenzinger, Albrecht, et al.
Publicado: (2014)

The combinatorial complexity of cancer precision medicine
por: Klauschen, Frederick, et al.
Publicado: (2014)

CognitionMaster: an object-based image analysis framework
por: Wienert, Stephan, et al.
Publicado: (2013)

Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading
por: Jesinghaus, Moritz, et al.
Publicado: (2022)

Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover
por: Denkert, Carsten, et al.
Publicado: (2008)

Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
por: Müller, Berit Maria, et al.
Publicado: (2013)

Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
por: Budczies, Jan, et al.
Publicado: (2017)

An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas
por: Noske, Aurelia, et al.
Publicado: (2011)

Mutations in POLE and survival of colorectal cancer patients – link to disease stage and treatment
por: Stenzinger, Albrecht, et al.
Publicado: (2014)

Ioncopy: an R Shiny app to call copy number alterations in targeted NGS data
por: Budczies, Jan, et al.
Publicado: (2018)

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo
por: Lehmann, Annika, et al.
Publicado: (2009)

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
por: Darb-Esfahani, Silvia, et al.
Publicado: (2015)

Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer
por: Kazdal, Daniel, et al.
Publicado: (2017)

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
por: Budczies, Jan, et al.
Publicado: (2012)

Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer
por: Arsenic, Ruza, et al.
Publicado: (2015)

Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
por: Stögbauer, Fabian, et al.
Publicado: (2023)

Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer
por: Goeppert, Benjamin, et al.
Publicado: (2015)

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Molecular driver alterations and their clinical relevance in cancer of unknown primary site
por: Löffler, Harald, et al.
Publicado: (2016)

CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
por: Niehr, Franziska, et al.
Publicado: (2015)

Struktur und Inhalt der EU-IVDR: Bestandsaufnahme und Implikationen für die Pathologie
por: Kahles, Andy, et al.
Publicado: (2022)

Structure and content of the EU-IVDR: Current status and implications for pathology
por: Kahles, Andy, et al.
Publicado: (2023)

Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität: Eine fokussierte Aktualisierung
por: Rüschoff, Josef, et al.
Publicado: (2023)

Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study
por: Budczies, Jan, et al.
Publicado: (2012)

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2009)

Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
por: Kriegsmann, Mark, et al.
Publicado: (2020)

Genetic changes of non-small cell lung cancer under neoadjuvant therapy
por: Warth, Arne, et al.
Publicado: (2016)

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
por: Baccelli, Irène, et al.
Publicado: (2014)

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2016)

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples
por: Kriegsmann, Katharina, et al.
Publicado: (2021)

Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes
por: Kriegsmann, Mark, et al.
Publicado: (2020)

Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery
por: Denkert, Carsten, et al.
Publicado: (2012)

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
por: Weichert, W, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_62gupoakjirrf6ohprof9nva92